Considering importance of N protein for study of viral pathogenesis or development of immunodiagnostic assay, we reported effects of several conditions on purity and homogeneity of recombinant SARS-CoV N protein expressed in E. coli BL21. The SARS-CoV N gene was reverse transcribed and amplified by the reverse transcription-polymerase chain reaction (RT-PCR) technique. The amplicons were cloned into pGEX-6P1 and followed by subcloning of the target gene into pQE-80L. After inserting the recombinant plasmid (pQE80-N) into E. coli, the recombinant protein (6 x His tag-N protein fusion) was expressed by inducing the bacterial cells with 0.1-0.5 mM isopropyl-1-thio-Dgalactopyranoside (IPTG) for 1-5 h. The protein recombinant were extracted from the bacterial cells by NTT buffer containing 0-20 mM imidazol, and followed by Ni-NTA affinity resin purification. The results showed that induction of E. coli BL21 with 0.2 mM IPTG for 4 h and followed with lysis of bacterial cells in NTT buffer containing 10 mM imidazol were optimal conditions to obtain the pure recombinant SARS-CoV N protein.
Introduction
Genome of severe acute respiratory syndrome coronavirus (SARS-CoV) is approximately 30 kb with a structural gene arrangement: 5'-Replicase (orf 1a)-Protease (orf 1b)-Spike (S)-Envelope (E)-membrane (M)-Nucleocapsid (N)-3' [1] . Among the SARS-CoV proteins, N protein constitutes an unique protein because of having a putative nuclear localization signal (KKDKKKK, a.a. 370-376), playing a role in replication and transcription of viral RNA [2] . Moreover, N protein is highly immunogenic and earliest expressed, and N protein-anti Abs are most abundant circulated during infection [3] [4] [5] [6] ; therefore, several groups developed the SARS-CoV N protein-based serological assays for SARS diagnosis [7] [8] [9] [10] [11] .
In this study, we report several parameters technically affecting on the purity of the purification of the recombinant SARS-CoV N protein expressed in E. coli BL21. The information is useful in the use of the recombinant SARS-CoV N protein to develop immunodiagnostic assay or to study viral pathogenesis.
Methods
Viral RNA standard and SARS positive sera. SARSCoV genome were obtained from Matthias Niedrig, Robert Koch-Institut Berlin and provided by the European Network for Diagnostics of "imported' Viral Diseases (ENIVD).
Cloning, Expression and purification of recombinant SARS-CoV N protein. Reverse transcription and PCR were performed with primers: forward (5'-GCG GATCCATGTCTGATAATGGACCCCAA-3') and reverse (5'-ACGTCGACTTATGCCTGAGTTGAATC-3'). N gene was ligated into BamHI and SalI sites of prokaryotic expression vector pGEX-6P1 (Amersham Pharmacia) and followed by subcloning the gene into vector pQE-80L (Qiagen) . The fidelity of the insert sequence and in frame between the insert and vector DNA sequences was confirmed by the sequence of recombinant DNA. The recombinant plasmid (pQE80-N) was transformed into E. coli strain BL21. The recombinant protein (6 x His tag-N protein fusion) was expressed by inducing the bacterial cells with 0.1-0.5 mM isopropyl-1-thio-D-galactopyranoside (IPTG) at 25   o   C  or 37 o C for 1-5 h. Bacterial pellets were sonicated and solubilized in lysis buffer from kit (50 mM NaH2PO4; 300 mM NaCl; 10 mM imidazole, pH 8.0 [Qiagen] ) or in NTT buffer (1.5% N-lauroylsarcosine, 1% Triton X-100, 150mM NaCl, and 10mM Tris, pH 8.0) containing 0-20 mM imidazol. Finally, purification of the recombinant protein was performed with following the manufacturer's instructions (Qiagen) . 
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Results and Discussion
Cloning of SARS-CoV N gene into pQE80L. Sequencing of the gene nucleotide was performed to confirm the exactness of SARS-CoV N nucleotide sequence and its in-frame with pQE80L. Based on the analysis, the nucleotide sequence showed 100% homology with the N gene of SARS-CoV strain Urbani (Genebank accession number: AAP13445) and was truly in-framed with pQE80L (data not shown).
Optimal time for expression of recombinant SARSCoV N protein.
To express protein, the pQE80-N was transformed into E. coli BL21 following protocol reported by Sambrook [12] . In order to know optimal time for expression of the recombinant protein, the cells containing the pQE80-N was induced with 1 mM at 37°C for 1-5 h. Since there was no significant difference between protein bands induced for 4 and 5 h (data not shown); thus, the optimal induction time in expressing the protein is for 4 h. 
Purification of recombinant SARS-CoV N protein.
To obtain pure recombinant proteins, the proteins were purified by Ni-NTA affinity resin. In purification procedure, washing and elution steps were performed five and four times, respectively. Result of each elution In this study, gene encoding N protein of SARS-CoV has been cloned into pQE-80L. The plasmid can be used as expression vector in all strains of E. coli cells including strain BL21 [13] . Thus, recombinant SARSCoV N protein has been expressed in E. coli BL21 and further purified by using Ni-NTA affinity resin. In expression and purification, we found one main problem i.e. the recombinant proteins formed inclusion body (Figure 1) . The inclusion body is a protein mass caused by hydrophobic interactions among the proteins during stages in forming protein secondary structures [13] . Several works reported that soluble level of particular recombinant protein expressed in E. coli cells can be increased by means of decreasing growth temperature (from 37 o C to 20 o C) when the bacterial cells were induced with IPTG [13] [14] [15] . However, we found no significant difference of the soluble level of the recombinant protein expressed in bacteria that was induced at 37 o C and 25 o C ( Figure 1 ). It is thought that the soluble level of the protein is unable to be detected visually because the quality of the solubility is involved in correct folding of certain protein while forming secondary structure.
In addition to temperature treatment, IPTG induction at particular concentration also influence the protein solubility [13] . In the present study, bacteria induced at 0.2 mM IPTG showed a protein band with less strong intensity in supernatant than in pellet phases. It means that induction at 0.2 mM IPTG lead the recombinant protein to more soluble but not optimal solubility (Figure 2) . To achieve the optimal protein solubility, we used NTT buffer to lyse the bacterial cells instead of the lysis buffer from kit. The NTT buffer was firstly reported by Chang and colleagues to lyse E. coli strain m15 expressing recombinant SARS-CoV N protein [2] . They found that the recombinant SARS-CoV N proteinanti polyclonal antibody recognized native SARS-CoV N protein on Vero E6 cell line that was infected by SARS-CoV [2] . According to their findings, it can be concluded that the NTT buffer can be used for lysis of E. coli cells expressing the recombinant SARS-CoV N protein without eliminating the native protein features.
Moreover, the lysis buffer containing N-lauroylsarcosine and Triton X-100 with low concentrations (≤2%) can be used for solving the inclusion bodies without eliminating native protein conformation [12, 16, 17] . Sambrook reported that 1.5% N-lauroylsarcosine and 1% Triton X-100 can be used to solve glutathine-Stransferase (GST)-fused proteins without interfering interactions between GST domains and glutathioneagarose resins in which the interactions are a native protein conformation-dependent interaction [12] . The evidences have also been proven previously in another study [18] .
Even though the solubility of the recombinant protein showed a better level when NTT buffer used as the lysis buffer, there were still protein contaminations from E. coli BL2 (Figure 4) . To eliminate protein contaminations, we added 10 mM or 20 mM imidazol into NTT buffer. Principle of the addition of the imidazol is that the lysis buffer containing 10-20 mM imidazol can reduce unspecific interactions between Ni-NTA resins and unexpected proteins; however, high imidazol concentration lead to dissociate specific interactions [13] .
A comparison study showed that NTT buffer containing 10 mM imidazol (NTT + 10 mM imidazol) yielded the recombinant proteins that were purer than NTT buffer containing 20 mM imidazol ( Figure 5 ). In addition, the NTT + 10 mM imidazol also led the recombinant protein bands to higher intensity ( Figure 5 ). Thus, 10 mM imidazol added into NTT buffer can increase the purity of the recombinant protein and is more efficient for purification of the recombinant protein compared with 20 mM imidazol or without imidazol. As shown in Figure 5 that there were truncated proteins detected on SDS-PAGE gel. The proteins were not contaminant proteins from E. coli BL21 but truncated SARS-CoV N proteins. We have proved the evidences by Western blot and enzyme-linked immusorbent assay (data not shown).
In conclusion, optimal expression and purification of recombinant SARS-CoV N protein in E. coli BL21 are conducted with the following two important conditions: bacterial cells were induced at 0.2 mM IPTG for 4 h and lysed in NTT buffer (1.5% N-lauroylsarcosine, 1% Triton X-100, 150mM NaCl, and 10mM Tris, pH 8.0) containing 10 mM imidazol.
